IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,040,000 | -10.3% | 182,555 | +2.9% | 0.54% | -5.1% |
| Q4 2021 | $3,388,000 | -22.3% | 177,463 | +0.4% | 0.56% | -24.5% |
| Q3 2021 | $4,361,000 | -3.5% | 176,837 | +1.8% | 0.75% | -3.6% |
| Q2 2021 | $4,519,000 | -17.4% | 173,691 | +0.5% | 0.78% | -28.7% |
| Q1 2021 | $5,470,000 | -32.0% | 172,759 | -0.4% | 1.09% | -29.4% |
| Q4 2020 | $8,045,000 | +34.2% | 173,383 | -4.8% | 1.54% | +18.6% |
| Q3 2020 | $5,997,000 | +19.7% | 182,173 | -0.2% | 1.30% | +2.8% |
| Q2 2020 | $5,009,000 | -6.7% | 182,488 | +1.7% | 1.26% | -28.9% |
| Q1 2020 | $5,370,000 | +5.4% | 179,399 | -2.5% | 1.78% | +51.3% |
| Q4 2019 | $5,095,000 | +51.5% | 184,085 | -0.4% | 1.18% | +36.7% |
| Q3 2019 | $3,364,000 | – | 184,835 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |